Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 3/20 | 0.32 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.32 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL146751 | 0.81 | SLC5A2 (0.41) | SLC5A2ABCB11ADORA3SLC5A1SLC6A4 | |
| SCHEMBL19312394 | 0.80 | LTA4H (0.34) | SLC5A2ABCB11ADORA3SLC5A1SLC6A4 | |
| SCHEMBL22510538 | 0.73 | SLC5A2 (0.44) | SLC5A2ABCB11ADORA3SLC5A1SLC6A4 | |
| SCHEMBL13472063 | 0.72 | SLC5A2 (0.38) | SLC5A2ABCB11ADORA3SLC5A1SLC6A4 | |
| SCHEMBL144713 | 0.72 | SLC5A2 (0.41) | SLC5A2ABCB11ADORA3SLC5A1SLC6A4 | |
| SCHEMBL148014 | 0.72 | SLC5A2 (0.41) | SLC5A2ABCB11ADORA3SLC5A1SLC6A4 | |
| SCHEMBL19677171 | 0.71 | SLC5A2 (0.40) | SLC5A2ABCB11ADORA3SLC5A1SLC6A4 | |
| SCHEMBL222357 | 0.71 | SLC5A2 (0.42) | SLC5A2ABCB11ADORA3SLC5A1SLC6A4 | |
| SCHEMBL147738 | 0.71 | SLC5A2 (0.42) | SLC5A2ABCB11ADORA3SLC5A1SLC6A4 | |
| SCHEMBL147505 | 0.68 | AR (0.38) | SLC5A2ABCB11ADORA3SLC5A1SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3251679-A1 | NOVEL COMPOUNDS HAVING INHIBITORY ACTIVITY AGAINST SODIUM-DEPENDANT GLUCOSE TRANSPORTER | Mitsubishi Tanabe Pharma Corporation (JP) | 2017-12-06 | — | — | EP | disclosed |